High‐efficiency and multilocus targeted integration in CHO cells using CRISPR‐mediated donor nicking and DNA repair inhibitors
Biotechnology and Bioengineering · 2023
DOI: 10.1002/bit.28393 ↗At a glance
Journal article in Biotechnology and Bioengineering, 2023. Written by Nathaniel K Hamaker and 1 co-authors. Institution: Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, Delaware, USA. Major MEDLINE topics: DNA Repair, CRISPR-Associated Protein 9. Cited 7 times so far (Crossref); 89 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIGMS NIH HHS, National Institutes of Health, National Institute of Standards and Technology.
Abstract (original language)
Efforts to leverage clustered regularly interspaced short palindromic repeats/CRISPR‐associated protein 9 (CRISPR/Cas9) for targeted genomic modifications in mammalian cells are limited by low efficiencies and heterogeneous outcomes. To aid method optimization, we developed an all‐in‐one reporter system, including a novel superfolder orange fluorescent protein (sfOrange), to simultaneously quantify gene disruption, site‐specific integration (SSI), and random integration (RI). SSI strategies that utilize different donor plasmid formats and Cas9 nuclease variants were evaluated for targeting accuracy and efficiency in Chinese hamster ovary cells. Double‐cut and double‐nick donor formats significantly improved targeting accuracy by 2.3–8.3‐fold and 19–22‐fold, respectively, compared to standard circular donors. Notably, Cas9‐mediated donor linearization was associated with increased RI events, whereas donor nicking minimized RI without sacrificing SSI efficiency and avoided low‐fidelity outcomes. A screen of 10 molecules that modulate the major mammalian DNA repair pathways identified two inhibitors that further enhance targeting accuracy and efficiency to achieve SSI in 25% of transfected cells without selection. The optimized methods integrated transgene expression cassettes with 96% efficiency at a single locus and with 53%–55% efficiency at two loci simultaneously in selected clones. The CRISPR‐based tools and methods developed here could inform the use of CRISPR/Cas9 in mammalian cell lines, accelerate mammalian cell line engineering, and support advanced recombinant protein production applications.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, Delaware, USA.
- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), University of Delaware, Newark, Delaware, USA.
ORCID profiles: Kelvin H Lee
Funding
- NIGMS NIH HHS
- National Institutes of Health
- National Institute of Standards and Technology
Cite
APA
Hamaker, N. K., & Lee, K. H. (2023). High‐efficiency and multilocus targeted integration in CHO cells using CRISPR‐mediated donor nicking and DNA repair inhibitors. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28393
Vancouver
Hamaker NK, Lee KH. High‐efficiency and multilocus targeted integration in CHO cells using CRISPR‐mediated donor nicking and DNA repair inhibitors. Biotechnology and Bioengineering. 2023. doi:10.1002/bit.28393
BibTeX
@article{Hamaker2023,
author = {Hamaker, Nathaniel K and Lee, Kelvin H},
title = {High‐efficiency and multilocus targeted integration in CHO cells using CRISPR‐mediated donor nicking and DNA repair inhibitors},
journal = {Biotechnology and Bioengineering},
year = {2023},
doi = {10.1002/bit.28393}
}
EUVIMED